Financial Aspects of Lung Cancer

Glen T. Schumock, Glen T. Schumock, Karen A. Fitzner, Karen A. Fitzner, Elizabeth A. Calhoun, Elizabeth A. Calhoun, Nicolle S. Gorby, Nicolle S. Gorby, Charles L. Bennett, Charles L. Bennett, Michael Wolf, Michael Wolf, Denise K. Finley, Denise K. Finley, Elizabeth A. Heckinger, Elizabeth A. Heckinger, Ahsan M. Arozullah, Ahsan M. Arozullah, The financial burden of cancer: estimates from a study of insured women with breast cancer. The journal of supportive oncology. ,vol. 2, pp. 271- 278 ,(2004)

David U. Himmelstein, Elizabeth Warren, Deborah Thorne, Steffie Woolhandler, Illness And Injury As Contributors To Bankruptcy Health Affairs. ,vol. 24, pp. W5- 63 ,(2005) , 10.1377/HLTHAFF.W5.63

Peter Darroch Hollett, J. Scott Sloka, Maria Mathews, Cost-effectiveness of positron emission tomography for non-small cell lung carcinoma in Canada Medical Science Monitor. ,vol. 10, ,(2004)

Markus Dietlein, Kerstin Weber, Afschin Gandjour, Detlef Moka, Peter Theissen, Karl W. Lauterbach, Harald Schicha, Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 27, pp. 1441- 1456 ,(2000) , 10.1007/S002590000324

B E Hillner, M K McDonald, C E Desch, T J Smith, L T Penberthy, P Maddox, S M Retchin, Costs of care associated with non-small-cell lung cancer in a commercially insured cohort. Journal of Clinical Oncology. ,vol. 16, pp. 1420- 1424 ,(1998) , 10.1200/JCO.1998.16.4.1420

P J Goodwin, F A Shepherd, Economic issues in lung cancer: a review. Journal of Clinical Oncology. ,vol. 16, pp. 3900- 3912 ,(1998) , 10.1200/JCO.1998.16.12.3900

Judith Mackay, Michael Eriksen, The Tobacco Atlas ,(2002)

Frank V. Fossella, Russell DeVore, Ronald N. Kerr, Jeffrey Crawford, Ronald R. Natale, Frank Dunphy, Leonard Kalman, Vincent Miller, Jin Soo Lee, Melvin Moore, David Gandara, Daniel Karp, Everett Vokes, Mark Kris, Yong Kim, Francis Gamza, Luz Hammershaimb, , Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens Journal of Clinical Oncology. ,vol. 18, pp. 2354- 2362 ,(2000) , 10.1200/JCO.2000.18.12.2354

C.C. Earle, R.H. Chapman, C.S. Baker, C.M. Bell, P.W. Stone, E.A. Sandberg, P.J. Neumann, Systematic Overview of Cost-Utility Assessments in Oncology Journal of Clinical Oncology. ,vol. 18, pp. 3302- 3317 ,(2000) , 10.1200/JCO.2000.18.18.3302

S S Gambhir, J E Shepherd, B D Shah, E Hart, C K Hoh, P E Valk, T Emi, M E Phelps, Analytical decision model for the cost-effective management of solitary pulmonary nodules. Journal of Clinical Oncology. ,vol. 16, pp. 2113- 2125 ,(1998) , 10.1200/JCO.1998.16.6.2113